Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Raltegravir in the Swiss HIV Cohort Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by University of Zurich.
Recruitment status was  Recruiting
Swiss HIV Cohort Study
Merck Sharp & Dohme Corp.
Information provided by:
University of Zurich Identifier:
First received: May 18, 2009
Last updated: May 19, 2009
Last verified: May 2009
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2012
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)